Seroba Life Sciences

Dublin, Ireland · VC · DeepTech Purist

About

Seroba Life Sciences Seroba Life Sciences is a European life sciences VC headquartered in Dublin, with Fund IV closed at €123M in February 2024. The fund targets up to 12 investments per vintage, with 5 already made including Perfuze, Sibylla Biotech, Deciphex, Complement Therapeutics, and Artica. The latest investment is Azafaros' Series B in May 2025, bringing total investments to 50. The LP base reads like a who's who of European development finance: EIF, Ireland Strategic Investment Fund (IS

Industries

Stage focus

Geography

Notable investments

Perfuze
Sibylla Biotech
Deciphex
Complement Therapeutics
Artica Therapeutics
Azafaros

Request removal →

Raising from Seroba Life Sciences?

I've worked with founders across the industrial stack. If Seroba Life Sciences is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.

Talk to Dan